Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

The top executives of Moderna, Akamai, and FMC just bought stock on the open market. All three shares are in the red for 2025 ...

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open ...

Moderna shares experienced a significant surge in trading on Thursday, posting a 5.58% gain in European markets and an impressive jump of up to 16% on the NASDAQ. This remarkable performance was ...

Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore ...

Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals JAZZ announced an agreement to acquire Chimerix CMRX. Meanwhile, other pipeline and regulatory ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

Wall Street rebondit grâce à l'exemption de droits de douane sur les véhicules La Bourse de New York a terminé en hausse ...

2025 Agence Option Finance (AOF) - Tous droits de reproduction réservés par AOF. AOF collecte ses données auprès des sources qu'elle considère les plus sûres. Toutefois, le lecteur reste seul responsa ...

REVUE DES MARCHÉS. La Bourse de New York a terminé en hausse mercredi, reprenant son souffle après plusieurs séances dans le ...

La Bourse de New York a terminé en hausse mercredi, reprenant son souffle après plusieurs séances dans le rouge, grâce à ...